Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2017	Jan. 03, 2016	Dec. 28, 2014
Cash flows from operating activities:
Net income	$ 129,624	$ 161,142	$ 121,434
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	124,304	153,732	159,860
Share-based compensation	18,141	23,231	28,243
Impairment of long-lived assets	16,241	25,001	19,613
Deferred income tax	(14,213)	89,026	69,540
Excess tax benefits from share-based compensation	(3,082)	(49,613)	(9,363)
Non-cash rent expense, net	(7,543)	3,364	1,951
Net receipt (recognition) of deferred vendor incentives	959	(2,559)	4,063
System optimization gains, net	(71,931)	(74,041)	(91,579)
Gain on disposal of the Bakery	0	(25,529)	0
Gain on sale of investments, net	(497)	(335)	(975)
Distributions received from TimWen joint venture	11,426	12,451	13,896
Equity in earnings in joint ventures, net	(8,351)	(9,205)	(10,176)
Long-term debt-related activities, net (see below)	11,767	8,075	3,625
Other, net	4,172	(4,318)	(11,686)
Changes in operating assets and liabilities:
Restricted cash	228	(23,640)	0
Accounts and notes receivable, net	(38,657)	(52,620)	(2,763)
Inventories	34	(62)	706
Prepaid expenses and other current assets	(3,276)	(5,409)	(2,976)
Accounts payable	(6,635)	(7,787)	(3,105)
Accrued expenses and other current liabilities	18,697	(8,424)	(35,532)
Net cash provided by operating activities	181,408	212,480	254,776
Cash flows from investing activities:
Capital expenditures	(150,023)	(251,622)	(298,471)
Acquisitions	(2,209)	(1,232)	(53,954)
Dispositions	262,173	204,388	161,386
Proceeds from sale of the Bakery	0	78,408	0
Changes in restricted cash	(14,971)	3,634	1,750
Notes receivable, net	(3,581)	3,289	434
Proceeds from Sale of Investment Projects	890	621	2,193
Payments to Acquire Investments	172	2,106	1,150
Net cash provided by (used in) investing activities	92,107	35,380	(187,812)
Cash flows from financing activities:
Proceeds from long-term debt	0	2,294,000	0
Repayments of long-term debt	(24,617)	(1,327,223)	(38,380)
Change in restricted cash	0	(5,687)	0
Deferred financing costs	(1,983)	(43,817)	0
Repurchases of common stock	(336,958)	(1,098,717)	(301,216)
Dividends	(63,832)	(71,845)	(75,117)
Proceeds from stock option exercises	19,773	27,952	30,788
Excess tax benefits from share-based compensation	3,082	49,613	9,363
Net cash used in financing activities	(404,535)	(175,724)	(374,562)
Net cash (used in) provided by operations before effect of exchange rate changes on cash	(131,020)	72,136	(307,598)
Effect of exchange rate changes on cash	2,044	(12,196)	(5,278)
Net (decrease) increase in cash and cash equivalents	(128,976)	59,940	(312,876)
Cash and cash equivalents at beginning of period	327,216	267,276	580,152
Cash and cash equivalents at end of period	198,240	327,216	267,276
Long-term debt-related activities, net:
Accretion of long-term debt	1,220	1,204	1,187
Amortization of deferred financing costs	7,653	5,426	2,438
Loss on early extinguishment of debt	0	7,295	0
Payments for termination of cash flow hedges	0	(7,337)	0
Reclassification of unrealized losses on cash flow hedges	2,894	1,487	0
Long-term debt-related activities, net:	11,767	8,075	3,625
Cash paid for:
Interest	117,583	84,326	52,357
Income taxes, net of refunds	77,620	41,275	15,826
Supplemental non-cash investing and financing activities:
Capital expenditures included in accounts payable	11,325	31,468	45,409
Capitalized lease obligations	104,119	57,226	22,255
Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction	512	0	0
Notes receivable	$ 0	$ 0	$ 3,934